Samsung Bio to step into peptides in $1.8B buy for PolyPeptide

July 20, 2026 12:18 PM EDT DealsPharmaManufacturing Sam­sung Bio to ex­pand its wheel­house in $1.8B buy for pep­tide API mak­er Anna Brown News Reporter Sam­sung Bi­o­log­ics is set to branch in­to pep­tide in­gre­di­ent man­u­fac­tur­ing with plans to buy Swiss CD­MO PolyPep­tide for $1.8 bil­lion in … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER